Literature DB >> 15311210

Induction of DNA methylation and gene silencing by short interfering RNAs in human cells.

Hiroaki Kawasaki1, Kazunari Taira.   

Abstract

Double-stranded RNAs (dsRNAs) induce post-transcriptional gene silencing in several species of animal and plant. In plants, dsRNAs targeted to CpG islands within a promoter can also induce RNA-directed DNA methylation; however, it remains unclear whether gene silencing mediated by DNA methylation can be induced by dsRNAs in mammalian cells. Here, we demonstrate that short interfering RNAs (siRNAs; 21-25-nucleotide RNA molecules) induce DNA methylation and histone H3 methylation in human cells. Synthetic siRNAs targeted to CpG islands of an E-cadherin promoter induced significant DNA methylation and histone H3 lysine 9 methylation in both MCF-7 and normal mammary epithelial cells. As a result, these siRNAs repressed expression of the E-cadherin gene at the transcriptional level. In addition, disrupting the expression of either one of two DNA methyltransferases (DNMT1 or DNMT3B) by specific siRNAs abolished the siRNA-mediated methylation of DNA. Moreover, vector-based siRNAs targeted to the erbB2 (also known as HER2) promoter also induced DNA methylation in MCF-7 cells. Thus, siRNAs targeted to CpG islands within the promoter of a specific gene can induce transcriptional gene silencing by means of DNA-methyltransferase-dependent methylation of DNA in human cells, and might have potential as a new type of gene therapeutic agent.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15311210     DOI: 10.1038/nature02889

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  81 in total

Review 1.  Metabolic programming, epigenetics, and gestational diabetes mellitus.

Authors:  Sara E Pinney; Rebecca A Simmons
Journal:  Curr Diab Rep       Date:  2012-02       Impact factor: 4.810

Review 2.  Long non-coding RNAs and cancer: a new frontier of translational research?

Authors:  R Spizzo; M I Almeida; A Colombatti; G A Calin
Journal:  Oncogene       Date:  2012-01-23       Impact factor: 9.867

Review 3.  Minireview: Switching on progesterone receptor expression with duplex RNA.

Authors:  Bethany A Janowski; David R Corey
Journal:  Mol Endocrinol       Date:  2010-06-30

4.  A SNF2-like protein facilitates dynamic control of DNA methylation.

Authors:  Tatsuo Kanno; Werner Aufsatz; Estelle Jaligot; Michael Florian Mette; Marjori Matzke; Antonius J M Matzke
Journal:  EMBO Rep       Date:  2005-07       Impact factor: 8.807

Review 5.  The role of heterochromatin in centromere function.

Authors:  Alison L Pidoux; Robin C Allshire
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-03-29       Impact factor: 6.237

6.  Homology-dependent methylation in primate repetitive DNA.

Authors:  Julien Meunier; Adel Khelifi; Vincent Navratil; Laurent Duret
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-29       Impact factor: 11.205

7.  Rasgrf1 imprinting is regulated by a CTCF-dependent methylation-sensitive enhancer blocker.

Authors:  Bongjune Yoon; Herry Herman; Benjamin Hu; Yoon Jung Park; Anders Lindroth; Adam Bell; Adam G West; Yanjie Chang; Aimee Stablewski; Jessica C Piel; Dmitri I Loukinov; Victor V Lobanenkov; Paul D Soloway
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

8.  Experimental validation of the regulated expression of large numbers of non-coding RNAs from the mouse genome.

Authors:  Timothy Ravasi; Harukazu Suzuki; Ken C Pang; Shintaro Katayama; Masaaki Furuno; Rie Okunishi; Shiro Fukuda; Kelin Ru; Martin C Frith; M Milena Gongora; Sean M Grimmond; David A Hume; Yoshihide Hayashizaki; John S Mattick
Journal:  Genome Res       Date:  2005-12-12       Impact factor: 9.043

9.  Silencing RNA: a novel treatment for pancreatic cancer?

Authors:  N R Lemoine
Journal:  Gut       Date:  2005-09       Impact factor: 23.059

Review 10.  The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic.

Authors:  Samuel Broder
Journal:  Antiviral Res       Date:  2009-12-16       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.